Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2008Current Opinion in Nephrology & Hypertension

An update on cyclooxygenase-2 expression and metabolites in the kidney

View Full Paper
Ask AI
Bookmark
Share

Design

Review

Authors

RHRaymond C. HarrisKanazawa University

Discussion

Loading...

Member takes

Implication

Advises against long-term COX-2 inhibitor use in renal disease; leaves open metabolite-specific targeting for future research.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Raymond C. Harris (2008) studied this question.

synapsesocial.com/papers/6a856a76d1e5e0588dd4d633https://doi.org/10.1097/mnh.0b013e3282f1bb7d
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Renal cortical cyclooxygenase 2 expression is differentially regulated by angiotensin II AT 1 and AT 2 receptors2006 · 64 citations
  2. 2Chronic cyclooxygenase-2 inhibition blunts low sodium-stimulated renin without changing renal haemodynamics2000 · 55 citations
  3. 3Low plasma renin and reduced renin secretory responses to acute stimuli in conscious COX-2-deficient mice2006 · 57 citations
  4. 4Luminal NaCl delivery regulates basolateral PGE2 release from macula densa cells2003 · 130 citations
  5. 5Prostaglandin E 2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells2005 · 59 citations